InsidersTradesSigma
Track the Bioceltix S.A. share price and the full management transaction log of the company, a publicly traded company based in Poland. Shares are quoted on the PL market, under the authority of KNF. Operating in the Health Care sector, Bioceltix S.A. has logged 1 insider filings. Market capitalisation: €445.9m. The latest transaction was filed on 18 May 2026 (Notification PDMR). All data is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Bioceltix S.A. Strong Buy (bullish), based on 1 analysts. Average price target: PLN 133.00.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 May 2026
Acerca de Bioceltix S.A.
Bioceltix S.A. es una empresa especializada en el sector de la salud y farmacéutico. Cotiza en el mercado XWAR.